Lung-Function Response To Tiotropium plus Olodaterol In Patients With COPD With β-Agonist Reversibility

被引：0
|
作者：
Tashkin, D. P. [1 ]
Ferguson, G. T. [2 ]
Clerisme-Beaty, E. [3 ]
Vob, F. [4 ]
Buhl, R. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[3] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6808
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility
    Rickard, Kathleen
    Bengtsson, Thomas
    Rheault, Tara
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [32] NUTRITIONAL-STATUS AND LUNG-FUNCTION IN PATIENTS WITH COPD
    OPENBRIER, D
    IRWIN, M
    ROGERS, R
    GOTTLIEB, G
    SHAH, M
    ANAND, S
    PENNOCK, B
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 140 - 140
  • [33] The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium plus olodaterol trials
    Ferguson, Gary T.
    Watz, Henrik
    Maltais, Francois
    Gronke, Lars
    Voss, Florian
    Buhl, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [34] Effects of tiotropium plus olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
    Singh, Dave
    Gaga, Mina
    Schmidt, Olaf
    Bjermer, Leif
    Groenke, Lars
    Voss, Florian
    Ferguson, Gary T.
    RESPIRATORY RESEARCH, 2016, 17
  • [35] The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history
    Wedzicha, Jadwiga
    Buhl, Roland
    De La Hoz, Alberto
    Voss, Florian
    Calverley, Peter M. A.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [36] Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers
    McGarvey, Lorcan
    Buhl, Roland
    Korducki, Lawrence
    Amatto, Valeria C.
    Tetzlaff, Kay
    Bjermer, Leif
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [37] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Initial Disease Severity
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] Quantitative analysis of paired inspiratory and expiratory CT correlates highly with lung function measurements in COPD patients under tiotropium-olodaterol respimat
    Herth, Felix J. F.
    Heussel, C. P.
    Weinheimer, Oliver
    Kauczor, Hu
    Wielpuetz, Mark
    Trudzinski, Franziska
    Trinkmann, Frederick
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [39] Efficacy and safety of tiotropium plus olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age
    Ferguson, Gary T.
    Karpel, Jill P.
    Clerisme-Beaty, Emmanuelle
    Groenke, L. Ars
    Voss, Florian
    Buhl, Roland
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2701 - 2710
  • [40] The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD
    Herth, Felix
    Hohlfeld, Jens M.
    Haas, Johannes
    de la Hoz, Alberto
    Jin, Xidong
    Kreitner, Karl-Friedrich
    Vogelmeier, Claus
    Vogel-Claussen, Jens
    Watz, Henrik
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
12345